198 related articles for article (PubMed ID: 11782573)
21. Hepatitis C virus-related chronic liver disease with autoantibodies to liver-kidney microsomes (LKM). Clinical characterization from idiopathic LKM-positive disorders.
Todros L; Touscoz G; D'Urso N; Durazzo M; Albano E; Poli G; Baldi M; Rizzetto M
J Hepatol; 1991 Jul; 13(1):128-31. PubMed ID: 1655868
[TBL] [Abstract][Full Text] [Related]
22. A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases.
Bayraktar Y; Bayraktar M; Gurakar A; Hassanein TI; Van Thiel DH
Hepatogastroenterology; 1997; 44(14):417-25. PubMed ID: 9164512
[TBL] [Abstract][Full Text] [Related]
23. Autoantibodies associated with acute rejection after liver transplantation for type-2 autoimmune hepatitis.
Duclos-Vallée JC; Johanet C; Bach JF; Yamamoto AM
J Hepatol; 2000 Jul; 33(1):163-6. PubMed ID: 10905602
[TBL] [Abstract][Full Text] [Related]
24. Relationships between non-occupational cadmium exposure and expression of nine cytochrome P450 forms in human liver and kidney cortex samples.
Baker JR; Satarug S; Reilly PE; Edwards RJ; Ariyoshi N; Kamataki T; Moore MR; Williams DJ
Biochem Pharmacol; 2001 Sep; 62(6):713-21. PubMed ID: 11551516
[TBL] [Abstract][Full Text] [Related]
25. Anti-LKM-1 antibodies determined by use of recombinant P450 2D6 in ELISA and western blot and their association with anti-HCV and HCV-RNA.
Seelig R; Renz M; Bünger G; Schröter H; Seelig HP
Clin Exp Immunol; 1993 Jun; 92(3):373-80. PubMed ID: 8390333
[TBL] [Abstract][Full Text] [Related]
26. Anti-CYP2D6 antibodies detected by quantitative radioligand assay and relation to antibodies to liver-specific arginase in patients with autoimmune hepatitis.
Kimura M; Tatsumi KI; Tada H; Izumi Y; Kaneko A; Kato M; Masuzawa M; Ikemoto M; Yabusaki Y; Hidaka Y; Amino N
Clin Chim Acta; 2002 Feb; 316(1-2):155-64. PubMed ID: 11750286
[TBL] [Abstract][Full Text] [Related]
27. Characterization of anti-liver-kidney microsome antibody (anti-LKM1) from hepatitis C virus-positive and -negative sera.
Yamamoto AM; Cresteil D; Homberg JC; Alvarez F
Gastroenterology; 1993 Jun; 104(6):1762-7. PubMed ID: 7684716
[TBL] [Abstract][Full Text] [Related]
28. Hepatic autoantigens in patients with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy.
Obermayer-Straub P; Perheentupa J; Braun S; Kayser A; Barut A; Loges S; Harms A; Dalekos G; Strassburg CP; Manns MP
Gastroenterology; 2001 Sep; 121(3):668-77. PubMed ID: 11522751
[TBL] [Abstract][Full Text] [Related]
29. Conformational epitopes on CYP2D6 are recognized by liver/kidney microsomal antibodies.
Duclos-Vallée JC; Hajoui O; Yamamoto AM; Jacz-Aigrain E; Alvarez F
Gastroenterology; 1995 Feb; 108(2):470-6. PubMed ID: 7530671
[TBL] [Abstract][Full Text] [Related]
30. [Heterogeneity of antimicrosomal autoantibodies in chronic hepatitis C virus infection and delta hepatitis].
Durazzo M; Costa C; Schmidt E; Loges S; Scaglione L; Touscoz AG; Smedile A; Manns MP; Rizzetto M; Pagano G
Ann Ital Med Int; 1995; 10(2):93-7. PubMed ID: 7542466
[TBL] [Abstract][Full Text] [Related]
31. Autoantibodies and defined target autoantigens in autoimmune hepatitis: an overview.
Dalekos GN; Zachou K; Liaskos C; Gatselis N
Eur J Intern Med; 2002 Aug; 13(5):293-303. PubMed ID: 12144908
[TBL] [Abstract][Full Text] [Related]
32. Differences in anti-LKM-1 autoantibody immunoreactivity to CYP2D6 antigenic sites between hepatitis C virus-negative and -positive patients.
Kitazawa E; Igarashi T; Kawaguchi N; Matsushima H; Kawashima Y; Hankins RW; Miyakawa H
J Autoimmun; 2001 Nov; 17(3):243-9. PubMed ID: 11712862
[TBL] [Abstract][Full Text] [Related]
33. Antipeptide antibodies against overlapping sequences differentially inhibit human CYP2D6.
Cribb A; Nuss C; Wang R
Drug Metab Dispos; 1995 Jul; 23(7):671-5. PubMed ID: 7587952
[TBL] [Abstract][Full Text] [Related]
34. Recurrent episodes of acute hepatitis associated with LKM-1 (cytochrome P450 2D6) antibodies in identical twin brothers.
Nolte W; Polzien F; Sattler B; Ramadori G; Hartmann H
J Hepatol; 1995 Dec; 23(6):734-9. PubMed ID: 8750174
[TBL] [Abstract][Full Text] [Related]
35. Autoantibodies against cytochrome P450s in sera of children treated with immunosuppressive drugs.
Lytton SD; Berg U; Nemeth A; Ingelman-Sundberg M
Clin Exp Immunol; 2002 Feb; 127(2):293-302. PubMed ID: 11876753
[TBL] [Abstract][Full Text] [Related]
36. Autoantibodies against cytochromes P-4502E1 and P-4503A in alcoholics.
Lytton SD; Helander A; Zhang-Gouillon ZQ; Stokkeland K; Bordone R; Aricò S; Albano E; French SW; Ingelman-Sundberg M
Mol Pharmacol; 1999 Feb; 55(2):223-33. PubMed ID: 9927612
[TBL] [Abstract][Full Text] [Related]
37. A novel assay for detecting antibodies to cytochrome P4502D6, the molecular target of liver kidney microsomal antibody type 1.
Kerkar N; Ma Y; Hussain M; Muratori L; Targett C; Williams R; Bianchi FB; Mieli-Vergani G; Vergani D
J Immunol Methods; 1999 Mar; 223(2):227-35. PubMed ID: 10089101
[TBL] [Abstract][Full Text] [Related]
38. Liver/kidney microsomal antibody type 1 targets CYP2D6 on hepatocyte plasma membrane.
Muratori L; Parola M; Ripalti A; Robino G; Muratori P; Bellomo G; Carini R; Lenzi M; Landini MP; Albano E; Bianchi FB
Gut; 2000 Apr; 46(4):553-61. PubMed ID: 10716687
[TBL] [Abstract][Full Text] [Related]
39. Hepatitis C virus infection associated with liver-kidney microsomal antibody type 1 (LKM1) autoantibodies in children.
Bortolotti F; Muratori L; Jara P; Hierro L; Verucchi G; Giacchino R; Barbera C; Zancan L; Guido M; Resti M; Pedditzi S; Bianchi F; Gatta A
J Pediatr; 2003 Feb; 142(2):185-90. PubMed ID: 12584542
[TBL] [Abstract][Full Text] [Related]
40. Frequency and significance of antibodies to P450IID6 protein in Japanese patients with chronic hepatitis C.
Nishioka M; Morshed SA; Kono K; Himoto T; Parveen S; Arima K; Watanabe S; Manns MP
J Hepatol; 1997 May; 26(5):992-1000. PubMed ID: 9186829
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
